Table 2 Post-randomization use of non-study antihypertensive drugs and statins
Site | Medications | Standard Practice | Polypill | P-value |
|---|---|---|---|---|
Kegalle Teaching Hospital | Antihypertensive use | 8/20 (40.0%) | 1/21 (4.8%) | < 0.01 |
| Â | Statin use | 5/20 (25.0%) | 0/21 (0.0%) | 0.01 |
Kandy Teaching Hospital | Antihypertensive use | 33/37 (89.2%) | 0/34 (0.0%) | < 0.01 |
| Â | Statin use | 29/37 (78.4%) | 2/30 (6.7%) | < 0.01 |
The National Hospital of Sri Lanka | Antihypertensive use | 51/54 (94.4%) | 45/50 (90.0%) | 0.40 |
| Â | Statin use | 41/54 (75.9%) | 35/50 (70.0%) | 0.50 |
All sites (Total Sample) | Antihypertensive use | 92/111 (82.9%) | 46/105 (43.8%) | < 0.01 |
| Â | Statin use | 75/111 (67.6%) | 37/101 (36.6%) | < 0.01 |